Bioventus Inc (BVS)
11.12
-0.04
(-0.31%)
USD |
NASDAQ |
Nov 14, 16:00
11.12
0.00 (0.00%)
After-Hours: 20:00
Bioventus Gross Profit (Annual): 328.19M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 328.19M |
| December 31, 2022 | 331.08M |
| December 31, 2021 | 302.71M |
| December 31, 2020 | 233.52M |
| December 31, 2019 | 249.21M |
| Date | Value |
|---|---|
| December 31, 2018 | 235.01M |
| December 31, 2015 | 179.31M |
| December 31, 2014 | 168.28M |
| December 31, 2013 | 161.00M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
233.52M
Minimum
2020
331.08M
Maximum
2022
288.94M
Average
302.71M
Median
2021
Gross Profit (Annual) Benchmarks
| Boston Scientific Corp | 9.895B |
| Insulet Corp | 1.160B |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 55.47M |
| Catheter Precision Inc | 0.412M |